Tags: Competition Manufacturing Pharmaceuticals May 24, 2004 re: Proposed settlement of infringement litigation with Teva Pharmaceuticals involving sharing of the exclusivity period for the drug Paraplatin. Documents Letter from Donald S. Clark to Richard J. Stark, dated May 24, 2004 (28.67 KB)